| HOME >> MEDICINE >> TECHNOLOGY |
16.8 %15.6 %16.4 %15.7 %Operating income
17.4 %21.6 %17.9 %19.7 %(a) Deal-related amortization(b) Restructuring charges related to Florida(c) Total tax effect for non-GAAP pre-tax adjustments(d) Acquisition-related costs of $1,095(e) Inventory step-up of $27,179(f) Proceeds from sale of pipeline development projects(g) Acquisition-related and severance costs of $9,381(h) Acquisition-related costs of $2,410Table IIPERRIGO COMPANYREPORTABLE SEGMENTSRECONCILIATION OF NON-GAAP MEASURES(in thousands)(unaudited)Three Months EndedConsumer HealthcareMarch 31, 2012March 26, 2011% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales
$
448,848$
-$
448,848$
425,025$
-$
425,0256 %6 %Cost of sales
311,1211,010
(a)
310,111289,825918
(a)
288,9077 %7 %Gross profit
137,7271,010138,737135,200918136,1182 %2 %Operating expenses
63,1051,411
(a)
61,69462,9961,210
(a)
61,7860 %(0)%Operating income
$
74,622$
2,421$
77,043$
72,204$
2,128$
74,3323 %4 %Selected ratios as a percentage of net salesGross profit
30.7 %30.9 %31.8 %32.0 %Operating expenses
14.1 %13.7 %14.8 %14.5 %Operating income
16.6 %17.2 %17.0 %17.5 %Nine Months EndedConsumer HealthcareMarch 31, 2012March 26, 2011% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales
$
,331,806$
-$
,331,806$
,251,125$
-$
,251,1256 %6 %Cost of sales
921,6703,038
(a)
918,632853,1192,414
(a)
850,7058 %8 %Gross profit
410,1363,038413,174398,0062,414400,4203 %3 %Operating expenses
193,7943,848
(a)
189,946179,0893,710
(a)
175,3798 %8 %Operating income
216,3426,886223,228218,9176,124225,041(1)%(1)%Selected ratios as a percentage of net salesGross profit
30.
'/>"/>
| SOURCE Perrigo Company Copyright©2010 PR Newswire. All rights reserved |